Kerendia 10 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F4D4U
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,060
Award facts
- Contract value 100% obligated
- $23,060.09 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $23,060.09 to AmerisourceBergen Drug Corp for the supply of Kerendia 10 mg tablets (30-count packages) on December 15, 2025, with completion scheduled for December 16, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999.00 global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor with an extensive portfolio of pharmaceutical deliveries to the Defense Logistics Agency and military healthcare systems. The company's federal contract awards demonstrate consistent capability in fulfilling competitive procurement requirements for brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains, including diabetes medications, neurological treatments, pain management pharmaceuticals, and antibiotics. This delivery order for Kerendia, a medication used in kidney disease treatment, exemplifies AmerisourceBergen's ongoing role in supplying essential pharmaceutical commodities to support Defense Health Agency operations and broader government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F4D4U?
SPE2DR26F4D4U was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 15, 2025.
How much is contract SPE2DR26F4D4U worth?
The government has obligated $23,060 on SPE2DR26F4D4U.
Is contract SPE2DR26F4D4U an order under another contract?
Yes. SPE2DR26F4D4U is a delivery order under SPE2DR25D3012, an indefinite delivery contract.
Was contract SPE2DR26F4D4U competed?
The extent of competition for SPE2DR26F4D4U was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award